Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
CDRT15 pseudogene 2 is a non-coding pseudogene located in the human genome, also referred to as CDRT15L1. As with other annotated pseudogenes, CDRT15P2 does not produce a functional protein. Its genomic context and sequence suggest it arose by duplication or partial retrotransposition of the CDRT15 gene, but it is not known to encode a protein or play any active role as a receptor, enzyme, transporter, or therapeutic target[1][3]. There is no evidence that CDRT15 pseudogene 2 participates in cellular or physiological processes directly, nor has it been associated with specific human diseases or used in clinical drug targeting. Some pseudogenes may engage in regulatory functions such as competing for microRNAs or interacting with RNA-binding proteins, but there is no data to suggest CDRT15P2 specifically plays such a role[2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CDRT15 pseudogene 2 (CDRT15P2).